Norepinephrine


Norepinephrine
Norepinephrine[1]
Identifiers
CAS number (l) 51-41-2 (l) N138-65-8(dl)
PubChem 439260
ChemSpider 388394 YesY
DrugBank DB00368
KEGG D00076 YesY
ChEBI CHEBI:18357 YesY
ChEMBL CHEMBL1437 YesY
Jmol-3D images Image 1
Properties
Molecular formula C8H11NO3
Molar mass 169.18 g mol−1
Density 1.397±0.06 g/cm^3 (20° C and 760 Torr)[2]
Melting point

L: 216.5–218 °C (decomp.)
D/L: 191 °C (decomp.)

Boiling point

442.6±40.0 °C (760 Torr)[2]

Vapor pressure 1.30e-8 Torr[2]
Acidity (pKa) 9.57±0.10[2]
 N (verify) (what is: YesY/N?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Norepinephrine (INN) (abbreviated norepi or NE) is the US name for noradrenaline (BAN) (abbreviated NA or NAd), a catecholamine with multiple roles including as a hormone and a neurotransmitter.[3] Areas of the body that produce or are affected by norepinephrine are described as noradrenergic.

The terms noradrenaline (from the Latin) and norepinephrine (derived from Greek) are interchangeable, with noradrenaline the common name in most parts of the world. However, to avoid confusion and achieve consistency medical authorities have promoted norepinephrine as the favoured nomenclature, and this is the term used throughout this article.

One of the most important functions of norepinephrine is its role as the neurotransmitter released from the sympathetic neurons affecting the heart. An increase in norepinephrine from the sympathetic nervous system increases the rate of contractions.[4]

As a stress hormone, norepinephrine affects parts of the brain, such as the amygdala, where attention and responses are controlled.[5] Along with epinephrine, norepinephrine also underlies the fight-or-flight response, directly increasing heart rate, triggering the release of glucose from energy stores, and increasing blood flow to skeletal muscle. It increases the brain's oxygen supply.[6] Norepinephrine can also suppress neuroinflammation when released diffusely in the brain from the locus coeruleus.[7]

When norepinephrine acts as a drug it increases blood pressure by increasing vascular tone (tension of muscles) through α-adrenergic receptor activation. The resulting increase in vascular resistance triggers a compensatory reflex that overcomes the direct homeostatic effect of that increase on the heart, called the baroreceptor reflex, which otherwise would result in a drop in heart rate called reflex bradycardia.

Norepinephrine is synthesized from dopamine by dopamine β-hydroxylase.[8] It is released from the adrenal medulla into the blood as a hormone, and is also a neurotransmitter in the central nervous system and sympathetic nervous system where it is released from noradrenergic neurons in the locus coeruleus. The actions of norepinephrine are carried out via the binding to adrenergic receptors.

Contents

Chemistry

Norepinephrine is a catecholamine and a phenethylamine. The natural stereoisomer is L-(−)-(R)-norepinephrine. The term "norepinephrine" is derived from the chemical prefix nor-, which indicates that norepinephrine is the next lower homolog of epinephrine. The two structures differ only in that epinephrine has a methyl group attached to its nitrogen, while the methyl group is replaced by a hydrogen atom in norepinephrine. The prefix nor- is likely derived as an abbreviation of the word "normal", used to indicate a demethylated compound.[9][10][11]

Origins

Norepinephrine is released when a host of physiological changes are activated by a stressful event.

In the brain, this is caused in part by activation of an area of the brain stems called the locus ceruleus. This nucleus is the origin of most norepinephrine pathways in the brain. Noradrenergic neurons project bilaterally (send signals to both sides of the brain) from the locus ceruleus along distinct pathways to many locations, including the cerebral cortex, limbic system, and the spinal cord, forming a neurotransmitter system.

Norepinephrine is also released from postganglionic neurons of the sympathetic nervous system, to transmit the fight-or-flight response in each tissue respectively. The adrenal medulla can also be counted to such postganglionic nerve cells, although they release norepinephrine into the blood.

Norepinephrine system

The noradrenergic neurons in the brain form a neurotransmitter system, that, when activated, exerts effects on large areas of the brain. The effects are alertness and arousal, and influences on the reward system.

Anatomically, the noradrenergic neurons originate both in the locus coeruleus and the lateral tegmental field. The axons of the neurons in the locus coeruleus act on adrenergic receptors in:

On the other hand, axons of neurons of the lateral tegmental field act on adrenergic receptors in hypothalamus, for example.

This structure explains some of the clinical uses of norepinephrine, since a modification of the system affects large areas of the brain.

Mechanism

Norepinephrine is synthesized from tyrosine as a precursor, and packed into synaptic vesicles. It performs its action by being released into the synaptic cleft, where it acts on adrenergic receptors, followed by the signal termination, either by degradation of norepinephrine, or by uptake by surrounding cells.

Biosynthesis

Norepinephrine is synthesized by a series of enzymatic steps in the adrenal medulla and postganglionic neurons of the sympathetic nervous system from the amino acid tyrosine:

Vesicular transport

Between the decarboxylation and the final β-oxidation, norepinephrine is transported into synaptic vesicles. This is accomplished by vesicular monoamine transporter (VMAT) in the lipid bilayer. This transporter has equal affinity for norepinephrine, epinephrine and isoprenaline.[12]

Release

To perform its functions, norepinephrine needs to be released from synaptic vesicles. Many substances modulate this release, some inhibiting it and some stimulating it.

For instance, there are inhibitory α2 adrenergic receptors presynaptically, that gives negative feedback on release by homotropic modulation.

Receptor binding

Norepinephrine performs its actions on the target cell by binding to and activating adrenergic receptors. The target cell expression of different types of receptors determines the ultimate cellular effect, and thus norepinephrine has different actions on different cell types.

Termination

Signal termination is a result of reuptake and degradation.

Uptake

Extracellular uptake of norepinephrine into the cytosol is either done presynaptically (uptake 1) or by non-neuronal cells in the vicinity (uptake 2). Furthermore, there is a vesicular uptake mechanism from the cytosol into synaptic vesicles.

Comparison of norepinephrine uptake
Uptake Transporter Vmax (nmol/g/min)[13] KM[13] Specificity[14] Location Other substrates[14] Inhibitors [15]
Uptake 1 Norepinephrine transporter[15] 1.2 0.3 norepinephrine > epinephrine > isoprenaline presynaptic
Uptake 2 100 250 epinephrine > norepinephrine > isoprenaline cell membrane of non-neuronal cells[12]
Vesicular VMAT[15] -[15] ~0.2[15] norepinephrine > epinephrine > isoprenaline[15] Synaptic vesicle membrane[15]

Degradation

Norepinephrine degradation. Enzymes are shown in boxes.[16]

In mammals, norepinephrine is rapidly degraded to various metabolites. The principal metabolites are:

  • Normetanephrine (via the enzyme catechol-O-methyl transferase, COMT)
  • 3,4-Dihydroxymandelic acid (via monoamine oxidase, MAO)
  • Vanillylmandelic acid (3-Methoxy-4-hydroxymandelic acid), also referred to as vanilmandelate or VMA (via MAO)
  • 3-Methoxy-4-hydroxyphenylethylene glycol, "MHPG" or "MOPEG" (via MAO)
  • Epinephrine (via PNMT)[17]

In the periphery, VMA is the major metabolite of catecholamines, and is excreted unconjugated in the urine. A minor metabolite (although the major one in the central nervous system) is MHPG, which is partly conjugated to sulfate or glucuronide derivatives and excreted in the urine.[18]

Noradrenergic agents

By indication

Norepinephrine may be used for the indications attention-deficit/hyperactivity disorder, depression and hypotension. Norepinephrine, as with other catecholamines, itself cannot cross the blood-brain barrier, so drugs such as amphetamines are necessary to increase brain levels.

Attention-deficit/hyperactivity disorder

Norepinephrine, along with dopamine, has come to be recognized as playing a large role in attention and focus. For people with ADHD, psychostimulant medications such as methylphenidate (Ritalin/Concerta), dextroamphetamine (Dexedrine), and Adderall (a mixture of dextroamphetamine and racemic amphetamine salts) are prescribed to help increase levels of norepinephrine and dopamine. Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor, and is a unique ADHD medication, as it affects only norepinephrine, rather than dopamine. As a result, Strattera has a lower abuse potential. However, it may not be as effective as the psychostimulants are with many people who have ADHD. Consulting with a physician is needed to find the appropriate medication and dosage. (Other SNRIs, currently approved as antidepressants, have also been used off-label for treatment of ADHD.)

Depression

Differences in the norepinephrine system are implicated in depression. Serotonin-norepinephrine reuptake inhibitors are antidepressants that treat depression by increasing the amount of serotonin and norepinephrine available to postsynaptic cells in the brain. There is some recent evidence implying that SNRIs may also increase dopamine transmission.[19] This is because SNRIs work by inhibiting reuptake, i.e. preventing the serotonin and norepinephrine transporters from taking their respective neurotransmitters back to their storage vesicles for later use. If the norepinephrine transporter normally recycles some dopamine too, then SNRIs will also enhance dopaminergic transmission. Therefore, the antidepressant effects associated with increasing norepinephrine levels may also be partly or largely due to the concurrent increase in dopamine (particularly in the prefrontal cortex of the brain).

Tricyclic antidepressants (TCAs) increase norepinephrine activity as well. Most of them also increase serotonin activity, but tend to produce unwanted side effects due to the nonspecific inactivation of histamine, acetylcholine and alpha-1 adrenergic receptors. Common side effects include sedation, dry mouth, constipation, sinus tachycardia, memory impairment, orthostatic hypotension, blurred vision and weight gain.[20] For this reason, they have largely been replaced by newer selective reuptake drugs. These include the SSRIs, e.g. fluoxetine (Prozac), which however have little or no effect on norepinephrine, and the newer SNRIs described above, such as venlafaxine (Effexor) and duloxetine (Cymbalta).

Schizophrenia

A commonly-known side effect associated with schizo-affective patients known as akathisia (commonly mistaken for schizophrenic symptoms) was found to be associated with increased levels of norepinephrine.[21] Data supports the efficacy of novel antipsychotics which deal with agonism of the NMDA glutamate receptors,[22] associated with regulating uptake of norepinephrine,[23] which in turn affects the trafficking of glutamate.[24] This suggests that schizophrenia may in fact have a greater association with abnormal norepinephrine-reuptake kinetics and less with dopamine, which may actually be responsible for a large part of the mechanism of glutamate release.[24]

Hypotension

Norepinephrine is also used as a vasopressor medication (for example, brand name Levophed) for patients with critical hypotension. It is given intravenously and acts on both α1 and α2 adrenergic receptors to cause vasoconstriction. Its effects are often limited to the increasing of blood pressure through agonist activity on α1 and α2 receptors and causing a resultant increase in peripheral vascular resistance. At high doses, and especially when it is combined with other vasopressors, it can lead to limb ischemia and limb death. Norepinephrine is mainly used to treat patients in vasodilatory shock states such as septic shock and neurogenic shock while showing fewer averse side effects compared to dopamine treatment.[25]

By site of action

Different medications affecting norepinephrine function have their targets at different points in the mechanism, from synthesis to signal termination.

Synthesis modulators

α-methyltyrosine is a substance that intervenes in norepinephrine synthesis by substituting tyrosine for tyrosine hydroxylase, and blocking this enzyme.

Vesicular transport modulators

This transportation can be inhibited by reserpine and tetrabenazine.[12]

Release modulators

Inhibitors of norepinephrine release
Substance[26] Receptor[26]
acetylcholine muscarinic receptor
norepinephrine (itself)/epinephrine α2 receptor
5-HT 5-HT receptor
adenosine P1 receptor
PGE EP receptor
histamine H2 receptor
enkephalin δ receptor
dopamine D2 receptor
ATP P2 receptor
Stimulators of norepinephrine release
Substance[26] Receptor[26]
adrenaline β2 receptor
angiotensin II AT1 receptor

Receptor binding modulators

Examples include alpha blockers for the α-receptors, and beta blockers for the β-receptors.

Termination modulators

Uptake modulators

Inhibitors[12] of uptake 1 include:

Inhibitors[12] of uptake 2 include:

Anti-Inflammatory agent role in Alzheimer’s Disease

The norepinephrine from locus ceruleus cells in addition to its neurotransmitter role locally diffuses from "varicosities". As such it provides an endogenous anti-inflammatory agent in the microenvironment around the neurons, glial cells, and blood vessels in the neocortex and hippocampus.[7] Up to 70% of norepinephrine projecting cells are lost in Alzheimer’s Disease. It has been shown that norepinephrine stimulates mouse microglia to suppress Aβ-induced production of cytokines and their phagocytosis of Aβ suggesting this loss might have a role in causing this disease.[7]

Nutritional sources

Shown here is the chemical structure of tyrosine. The biosynthesis of norepinephrine depends upon the presence of tyrosine, an amino acid building block of many proteins in meat, nuts and eggs, for example.

The synthesis of norepinephrine depends on the presence of tyrosine, an amino acid found in proteins such as meat, nuts, and eggs. Dairy products such as cheese also contain high amounts of tyrosine (the amino acid is named for "tyros", the Greek word for cheese). However, the body can synthesise tyrosine from phenylalanine, an essential amino acid. Tyrosine is the precursor to dopamine, which in turn is a precursor to epinephrine and norepinephrine.

Serotonin, a neurotransmitter that is in many ways the opposite of the catecholamines, is also directly synthesized from an amino acid (tryptophan). However, tryptophan has a somewhat different process of degradation. When serotonin is catabolized in the body, it does not break down into useful substrates in the way that dopamine is further degraded into epinephrine and norepinephrine. Instead, it breaks down into 5-hydroxyindoleacetic acid (5-HIA), an organic acid which may be harmful in high amounts. Tryptophan can further be catabolized into kynurenate, quinolinate, and picolinate, harmful substances that are generally regarded as markers of bodily inflammation.

Banana peels contain significant amounts of norepinephrine and dopamine.[27]

See also

External links

References

  1. ^ Merck Index, 11th Edition, 6612.
  2. ^ a b c d e "51-41-2". SciFinder. SciFinder. https://scifinder-cas-org.proxy.library.nd.edu:9443/scifinder/view/scifinder/scifinderExplore.jsf. Retrieved 14 November 2011. 
  3. ^ "Norepinephrine definition". dictionary.reference.com. http://dictionary.reference.com/browse/Norepinephrine. Retrieved 2008-11-24. 
  4. ^ Guyton, Arthur; Hall, John (2006). "Chapter 10: Rhythmical Excitation of the Heart". In Gruliow, Rebecca (Book). Textbook of Medical Physiology (11th ed.). Philadelphia, Pennsylvania: Elsevier Inc.. p. 122. ISBN 0-7216-0240-1. 
  5. ^ Tanaka2000 Tanaka M, et al. (2000). Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. doi:10.1016/S0014-2999(00)00569-0
  6. ^ The Hormone Foundation. "The Endocrine System & Types of Hormones."
  7. ^ a b c Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, Jardanhazi-Kurutz D, Walter J, Kirchhoff F, Hanisch UK, Kummer MP. (2010). Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A. 17:6058–6063 doi:10.1073/pnas.0909586107 PMID 20231476
  8. ^ "Introduction to Autonomic Pharmacology" (PDF). Elsevier International. http://www.fleshandbones.com/readingroom/pdf/225.pdf.  Link redirected to commercial site!
  9. ^ Sharma B, Satish A, Kumar R (1999). Dictionary of Drugs. Anmol Publications. ISBN 8126118202. http://books.google.com/?id=3JvArcoG2voC&printsec=frontcover#PPA166. 
  10. ^ Gaddum JH (June 1956). "The Prefix 'Nor' in Chemical Nomenclature". Nature 177 (1046): 1046–1046. doi:10.1038/1771046b0. 
  11. ^ Matthiessen A, Foster GC (1868). "Researches into the chemical constitution of narcotine and of its products of decomposition". Journal of the Chemical Society 358. http://books.google.com/?id=tKsOAAAAIAAJ&printsec=titlepage. 
  12. ^ a b c d e Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 167
  13. ^ a b These values are from rat heart. Unless else specified in table, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 167
  14. ^ a b Unless else specified in table, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 167
  15. ^ a b c d e f g h i j k l Unless else specified in boxes, then ref is: Rod Flower; Humphrey P. Rang; Maureen M. Dale; Ritter, James M. (2007). Rang & Dale's pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-06911-5. 
  16. ^ Figure 11-4 in: Rod Flower; Humphrey P. Rang; Maureen M. Dale; Ritter, James M. (2007). Rang & Dale's pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-06911-5. 
  17. ^ "Endokrynologia Kliniczna" ISBN 83-200-0815-8, page 502
  18. ^ Chapter 11 in: Rod Flower; Humphrey P. Rang; Maureen M. Dale; Ritter, James M. (2007). Rang & Dale's pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-06911-5. 
  19. ^ http://stahlonline.cambridge.org/prescribers_drug.jsf?page=0521683505c95_p539-544.html.therapeutics&name=Venlafaxine&title=Therapeutics
  20. ^ http://www.preskorn.com/columns/9803.html
  21. ^ http://books.google.com/books?id=AQeQa5AtpXoC&pg=PA215&lpg=PA215&source=bl&ots=_AZBdDkZOg&sig=cyrLwQRUUijGlvTRNVpmKoLJmpc&hl=en&ei=C9HMTI3mJ5DSsAPbhNzzDg&sa=X&oi=book_result&ct=result&resnum=2&ved=0CBcQ6AEwAQ#v=onepage&q&f=false
  22. ^ http://www.nature.com/npp/journal/v31/n4/abs/1300838a.html
  23. ^ http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WN4-4CCGGN1-9P&_user=10&_coverDate=11%2F30%2F1984&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_searchStrId=1520587233&_rerunOrigin=scholar.google&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5e43884bdf1f204eb2356e02096708bc&searchtype=a
  24. ^ a b http://sciencelinks.jp/j-east/article/200707/000020070707A0194475.php
  25. ^ De Backer, Daniel; et al. (March 4, 2010). "Comparison of Dopamine and Norepinephrine in the Treatment of Shock". New England Journal of Medicine 362 (9): 11. 
  26. ^ a b c d Unless else specified in table, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 129
  27. ^ Kanazawa, Kazuki; Hiroyuki Sakakibara (2000). "High content of Dopamine, a strong antioxidant, in Cavendish banana" (PDF). Journal of Agriculture and Food Chemistry 48 (3): 844–848. doi:10.1021/jf9909860. http://152.1.118.33/Files/Journal%20of%20Agricultural%20and%20Food%20Chemistry%202000%2048%20(3)%20844-848.pdf. Retrieved 8 November 2007. 

Wikimedia Foundation. 2010.

Look at other dictionaries:

  • norepinephrine — orepinephrine n. A hormone ({C8H11NO3}) secreted by the adrenal medulla; it also serves as a neurotransmitter, released at synapses; called also {noradrenaline}. Chemically it is 2 amino 1 (3,4 dihydroxyphenyl)ethanol. It is a precursor of… …   The Collaborative International Dictionary of English

  • norepinephrine — (n.) 1868, from NORMAL (Cf. normal) (in reference to molecular structure) + EPINEPHRINE (Cf. epinephrine) …   Etymology dictionary

  • norepinephrine — [nôr′ep΄ə nef′rin, nôr′ep΄ə nef′rēn΄] n. [see NOR ] a hormone or neurotransmitter, C8H11NO3, related to epinephrine, that is used medically to constrict blood vessels and to stop bleeding: it is secreted by the adrenal medulla or liberated at… …   English World dictionary

  • Norépinéphrine — Noradrénaline Noradrénaline Structure chimique de la noradrénaline Général …   Wikipédia en Français

  • norepinephrine — /nawr ep euh nef rin, reen/, n. 1. Also called noradrenaline. Physiol. a neurotransmitter, released by adrenergic nerve terminals in the autonomic and possibly the central nervous system, that has such effects as constricting blood vessels,… …   Universalium

  • norepinephrine — A chemical made by some nerve cells and in the adrenal gland. It can act as both a neurotransmitter (a chemical messenger used by nerve cells) and a hormone (a chemical that travels in the blood and controls the actions of other cells or organs) …   English dictionary of cancer terms

  • norepinephrine — noun Date: 1945 a monoamine C8H11NO3 that is a neurotransmitter in postganglionic neurons of the sympathetic nervous system and in some parts of the central nervous system, is a vasopressor hormone of the adrenal medulla, and is a precursor of… …   New Collegiate Dictionary

  • norepinephrine — See noradrenaline …   Dictionary of molecular biology

  • norepinephrine — noun A neurotransmitter found in the locus coeruleus which is synthesized from dopamine. Syn: noradrenaline See Also: epinephrine …   Wiktionary

  • norepinephrine — l (−) α (aminomethyl) 3,4 dihydroxybenzyl alcohol; a catecholamine hormone of which the natural form is d, although the l form has some activity; the base is considered to be the postganglionic adrenergic mediator, acting on α and β receptors; it …   Medical dictionary


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.